These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Kreipe H; Wacker HH; Heidebrecht HJ; Haas K; Hauberg M; Tiemann M; Parwaresch R Am J Pathol; 1993 Jun; 142(6):1689-94. PubMed ID: 7685150 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas. Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062 [TBL] [Abstract][Full Text] [Related]
4. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies. Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572 [TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas. Kalmanti M; Kanavaros P; Sakalidou A; Tzardi M; Datseris G; Bolonaki E; Kalmantis T; Kazlaris E; Delides G Acta Morphol Hung; 1992; 40(1-4):215-21. PubMed ID: 1365765 [TBL] [Abstract][Full Text] [Related]
6. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies. Wang PL; Peh SC Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243 [TBL] [Abstract][Full Text] [Related]
7. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen. Fournel-Fleury C; Magnol JP; Chabanne L; Ghernati I; Marchal T; Bonnefond C; Bryon PA; Felman P J Comp Pathol; 1997 Jul; 117(1):61-72. PubMed ID: 9263844 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings. Botticelli AR; Casali AM; Botticelli L; Zaffe D Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190 [TBL] [Abstract][Full Text] [Related]
9. [Malignant and benign lymphomas: histologic classification and immunomorphologic studies. Results of 838 cases]. Radaszkiewicz T Wien Klin Wochenschr; 1980 Dec; 92(23):819-33. PubMed ID: 6985528 [TBL] [Abstract][Full Text] [Related]
10. A comparison of Ki67 immunostaining and nucleolar organiser region staining in non-Hodgkin's lymphoma. P. A. Hall, J. Crocker, A. Watts, A. G. Stansfeld. Histopathology 1988; 12; 373-381 & Detection of the Ki67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB1.D. McCormick, H. Chong, C. Hobbs, C. Datta &P. A. Hall. Histopathology 1993; 22; 355-360. Hall PA Histopathology; 2002 Sep; 41(3A):111-4; discussion 114. PubMed ID: 12405939 [No Abstract] [Full Text] [Related]
11. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for DNA topoisomerase II in non-Hodgkin's lymphomas. Holden JA; Perkins SL; Snow GW; Kjeldsberg CR Am J Clin Pathol; 1995 Jul; 104(1):54-9. PubMed ID: 7611182 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670 [TBL] [Abstract][Full Text] [Related]
14. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. Spina D; Leoncini L; Del Vecchio MT; Megha T; Minacci C; Poggi SA; Pileri S; Tosi P; Kraft R; Laissue JA J Pathol; 1995 Dec; 177(4):335-41. PubMed ID: 8568587 [TBL] [Abstract][Full Text] [Related]
15. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas. Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology. Mathur S; Dawar R; Verma K Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258 [TBL] [Abstract][Full Text] [Related]
17. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938 [TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material. Rabenhorst SH; Burini RC; Schmitt FC Pathology; 1996 Jan; 28(1):12-6. PubMed ID: 8714262 [TBL] [Abstract][Full Text] [Related]
19. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation]. Nizze H; Bühring U Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions. Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]